The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. (Q45948359)

18 December 2017

title

The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. (English)

1 reference

18 December 2017

0 references

1 reference

5

Michal Tendera

1 reference

18 December 2017

author name string

Christian J F Holubarsch

1

1 reference

18 December 2017

Wilson S Colucci

2

1 reference

18 December 2017

Thomas Meinertz

3

1 reference

18 December 2017

Wilhelm Gaus

4

1 reference

18 December 2017

Survival and Prognosis: Investigation of Crataegus Extract WS 1442 in CHF (SPICE) trial study group

6

1 reference

18 December 2017

publication date

18 November 2008

1 reference

18 December 2017

European Journal of Heart Failure

published in

1 reference

18 December 2017

volume

10

1 reference

18 December 2017

issue

12

1 reference

18 December 2017

page(s)

1255-1263

1 reference

18 December 2017

Crataegus extract prolongs action potential duration in guinea-pig papillary muscle

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Beta-blockers and amiodarone for the primary prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

Adverse-event profile of Crataegus spp.: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.10.004

10.1016/J.EJHEART.2008.10.004

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19019730

1 reference

18 December 2017